Cargando…
Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy
X-linked myotubular myopathy (XLMTM) is a fatal congenital disorder caused by mutations in the MTM1 gene. Currently, there are no approved treatments, although AAV8-mediated gene transfer therapy has shown promise in animal models and preliminarily in patients. However, 4 patients with XLMTM treated...
Autores principales: | Karolczak, Sophie, Deshwar, Ashish R., Aristegui, Evangelina, Kamath, Binita M., Lawlor, Michael W., Andreoletti, Gaia, Volpatti, Jonathan, Ellis, Jillian L., Yin, Chunyue, Dowling, James J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503795/ https://www.ncbi.nlm.nih.gov/pubmed/37490339 http://dx.doi.org/10.1172/JCI166275 |
Ejemplares similares
-
X-linked recessive myotubular myopathy with MTM1 mutations
por: Han, Young-Mi, et al.
Publicado: (2013) -
Two Cases of X-Linked Myotubular Myopathy with Novel MTM1 Mutations
por: Lee, Eun Hye, et al.
Publicado: (2013) -
A novel intronic mutation in MTM1 detected by RNA analysis in a case of X-linked myotubular myopathy
por: Al-Hashim, Aqeela, et al.
Publicado: (2017) -
X‐linked myotubular myopathy associated with an MTM1 variant in a Maine coon cat
por: Kopke, Matthew A., et al.
Publicado: (2022) -
Three novel MTM1 pathogenic variants identified in Japanese patients with X‐linked myotubular myopathy
por: Nishikawa, Atsuko, et al.
Publicado: (2019)